Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6411
    -0.0015 (-0.23%)
     
  • OIL

    81.86
    -0.87 (-1.05%)
     
  • GOLD

    2,387.90
    -10.10 (-0.42%)
     
  • Bitcoin AUD

    101,197.61
    +3,227.43 (+3.29%)
     
  • CMC Crypto 200

    1,337.39
    +24.76 (+1.92%)
     
  • AUD/EUR

    0.6019
    -0.0011 (-0.19%)
     
  • AUD/NZD

    1.0891
    +0.0016 (+0.15%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,827.00
    -50.05 (-0.64%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,692.10
    -145.30 (-0.81%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

HLN or SYK: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Haleon PLC Sponsored ADR (HLN) and Stryker (SYK). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.

Currently, Haleon PLC Sponsored ADR has a Zacks Rank of #2 (Buy), while Stryker has a Zacks Rank of #3 (Hold). Investors should feel comfortable knowing that HLN likely has seen a stronger improvement to its earnings outlook than SYK has recently. However, value investors will care about much more than just this.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

ADVERTISEMENT

Our Value category highlights undervalued companies by looking at a variety of key metrics, including the popular P/E ratio, as well as the P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that have been used by value investors for years.

HLN currently has a forward P/E ratio of 18.24, while SYK has a forward P/E of 27.40. We also note that HLN has a PEG ratio of 2.59. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. SYK currently has a PEG ratio of 2.91.

Another notable valuation metric for HLN is its P/B ratio of 1.88. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, SYK has a P/B of 6.25.

These are just a few of the metrics contributing to HLN's Value grade of B and SYK's Value grade of C.

HLN stands above SYK thanks to its solid earnings outlook, and based on these valuation figures, we also feel that HLN is the superior value option right now.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Haleon PLC Sponsored ADR (HLN) : Free Stock Analysis Report

Stryker Corporation (SYK) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research